A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 3,756 shares of HAE stock, worth $296,724. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,756
Previous 2,644 42.06%
Holding current value
$296,724
Previous $225,000 37.78%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$81.24 - $97.37 $90,338 - $108,275
1,112 Added 42.06%
3,756 $310,000
Q1 2024

May 09, 2024

SELL
$71.24 - $85.35 $136,638 - $163,701
-1,918 Reduced 42.04%
2,644 $225,000
Q4 2023

Feb 07, 2024

BUY
$80.59 - $92.61 $367,651 - $422,486
4,562 New
4,562 $390,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.05B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.